HCPCS Level IIdrugActive
J7192
Factor viii recombinant nos
BETOS: O1E
Effective: 2010-01-01
Referenced in 5 policies
Description
Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Recombinate
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
1 IU
Billing Units
1.0000
12
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.